Acadia Pharmaceuticals Inc. ACAD
$28.02
+0.57%
at last close
Financials (TTM)
- Revenue
- $1.14 billion
- Net Income
- $380.48 million
- Net Margin
- 33.42%
- Return on Equity
- 29.12%
- Debt-to-Equity
- —
- P/E Ratio
- 12.57
- Price / Book
- 3.70
- Price / Sales
- 4.24
Over the trailing twelve months, Acadia Pharmaceuticals Inc. generated revenue of $1.14 billion and net income of $380.48 million, a net margin of 33.42%.
At the last closing price of $28.02, ACAD trades at 12.57 times trailing earnings and 4.24 times sales, with a market capitalization of $4.83 billion.
Key Stats
- Last Close
- $28.02
- Market Cap
- $4.83 billion
- 52-Week Range
- $19.69 – $30.96
- Average Volume
- 1.66 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.